| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.004 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |